Menu
Start Screening

Frontier mental health research: psychedelics & drug studies

Each month our editorial team sifts through hundreds of papers and curates notable findings—for practitioners and informed readers who want to stay current with the evidence. Subscribe to the monthly Research Digest for expert analysis and concise summaries of key papers.

Posttraumatic Stress Disorder Research Quality of life (healthcare)

1 paper

The cost-effectiveness of MDMA-assisted psychotherapy for the treatment of chronic, treatment-resistant PTSD

Elliot Marseille, James G. Kahn, Berra Yazar‐Klosinski, Rick Doblin
PLoS ONE Summary & key facts 2020 53 citations

MAPS reports results from a randomized, blinded Phase 3 trial of MDMA-assisted therapy for severe, chronic PTSD (90 people, average 14 years of PTSD). After three MDMA-assisted therapy sessions, 67% of treated participants no longer met the study's PTSD diagnosis and 88% had a clinically meaningful symptom drop, compared with…

Cannabis and Cannabinoid Research Posttraumatic Stress Disorder Research Psychedelics and Drug Studies
Summaries and links are for general information and education only. They are not a substitute for reading the original publication or for professional medical, legal, or other advice. Always refer to the linked source for the full study.